MetLife Investment Management’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,059
Closed -$110K 2800
2024
Q4
$110K Buy
+13,059
New +$103K ﹤0.01% 2576
2024
Q3
Sell
-4,527
Closed -$30.9K 2866
2024
Q2
$30.9K Sell
4,527
-5,156
-53% -$37.9K ﹤0.01% 2846
2024
Q1
$83K Hold
9,683
﹤0.01% 2619
2023
Q4
$102K Hold
9,683
﹤0.01% 2599
2023
Q3
$93.3K Hold
9,683
﹤0.01% 2614
2023
Q2
$93.2K Buy
+9,683
New +$87.7K ﹤0.01% 2720
2022
Q1
Sell
-6,986
Closed -$119K 2749
2021
Q4
$119K Hold
6,986
﹤0.01% 2342
2021
Q3
$91K Buy
+6,986
New +$114K ﹤0.01% 2476
2021
Q2
Sell
-6,622
Closed -$135K 2458
2021
Q1
$135K Buy
+6,622
New +$124K ﹤0.01% 2220

Other funds holding INFU

MetLife Investment Management's INFU Position: Q1 2025 in Review

MetLife Investment Management sold out of InfuSystem Holdings (INFU) in Q1 2025, closing a stake of 13,059 shares — an estimated $110K sold.

MetLife Investment Management first reported a position in INFU in Q1 2021 and held it in 9 quarters. The position peaked at $135K in Q1 2021. 94 funds tracked by Wall St. Rank hold INFU as of Q1 2025.

  • MetLife Investment Management reported no remaining InfuSystem Holdings position as of Q1 2025 after selling out during the quarter.
  • MetLife Investment Management sold 13,059 InfuSystem Holdings shares in Q1 2025, an estimated $110K.
  • MetLife Investment Management first reported a position in InfuSystem Holdings in Q1 2021 and held it in 9 quarters.
  • MetLife Investment Management's InfuSystem Holdings position peaked at $135K in Q1 2021.
  • 94 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2025.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.